Serial Number
98975225
Owner
Day One Biopharmaceuticals, Inc.Attorney
Maury M. Tepper, IIIFirst Use Date
Apr 23, 2024
Filing Date
Sep 21, 2023
DAY ONE BIOPHARMACEUTICALS Trademark
Serial Number: 98975225 • Registration: 8189842
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
1800 Sierra Point Parkway, Suite 200
Brisbane, CA 94005
Entity Type: 03
Legal Representation
Correspondence Address
Maury M. Tepper, III Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh, NC 27609
United States
Trademark Details
Filing Date
September 21, 2023
Registration Date
March 24, 2026
First Use Anywhere
April 23, 2024
First Use in Commerce
April 23, 2024
Published for Opposition
May 20, 2025
Goods & Services
Educational services, namely, providing online newsletters in the field of prescription drug information via emails, non-downloadable webinars, and online non-downloadable videos in the field of prescription drug information; educational services, namely, providing prescription drug dosage training; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma; providing information regarding tumors and cancer, and pediatric low-grade glioma
Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; financial services, namely, assessing sources of and facilitating access by patients and their families to financial support from copay support, patient assistance programs (PAP), patient foundations and organizations; financial services, namely, administration of patient reimbursement programs
Pharmaceutical preparations for human use for treating cancer and oncological diseases; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological, neurological, and immune system related diseases and disorders; medical preparations for the delivery of compounds to the body for the treatment and prevention of oncological, neurological, and immune system related diseases and disorders
Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological, neurological, and immune system diseases and disorders; research, development, and medical evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of oncological, neurological, and immune system related diseases and disorders